Neuland Laboratories Ltd
NSE:NEULANDLAB

Watchlist Manager
Neuland Laboratories Ltd Logo
Neuland Laboratories Ltd
NSE:NEULANDLAB
Watchlist
Price: 14 904.95 INR 0.93% Market Closed
Market Cap: 191.2B INR
Have any thoughts about
Neuland Laboratories Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Neuland Laboratories Ltd

Current Assets 9.2B
Cash & Short-Term Investments 1.2B
Receivables 3.7B
Other Current Assets 4.3B
Non-Current Assets 9.1B
Long-Term Investments 287.7m
PP&E 5.7B
Intangibles 2.8B
Other Non-Current Assets 321.8m
Current Liabilities 4.3B
Accounts Payable 1.9B
Other Current Liabilities 2.4B
Non-Current Liabilities 1.2B
Long-Term Debt 541.2m
Other Non-Current Liabilities 680.5m

Balance Sheet
Neuland Laboratories Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
8
70
34
33
79
112
24
51
454
1 646
Cash
8
70
34
33
79
112
24
51
454
876
Cash Equivalents
0
0
0
0
0
0
0
0
0
771
Short-Term Investments
0
0
75
75
75
432
233
185
136
291
Total Receivables
1 898
1 618
2 055
2 318
2 010
2 253
2 558
2 689
3 967
4 269
Accounts Receivables
1 288
1 277
1 812
1 952
1 658
1 920
2 207
2 632
3 912
4 198
Other Receivables
610
341
243
366
352
333
351
57
56
71
Inventory
1 134
1 427
1 460
1 857
2 013
2 285
2 607
2 802
2 945
3 662
Other Current Assets
118
107
126
189
357
70
73
81
107
114
Total Current Assets
3 158
3 223
3 750
4 472
4 535
5 152
5 496
5 808
7 609
9 211
PP&E Net
1 638
1 894
1 746
2 899
3 349
3 651
4 312
4 866
4 980
5 686
PP&E Gross
1 638
1 894
1 746
2 899
3 349
3 651
4 312
4 866
4 980
5 686
Accumulated Depreciation
1 388
0
185
371
615
883
1 219
1 595
2 049
2 568
Intangible Assets
8
5
13
18
18
20
35
21
13
25
Goodwill
0
2 795
2 795
2 795
2 795
2 795
2 795
2 795
2 795
2 795
Note Receivable
238
142
219
198
274
358
506
85
125
320
Long-Term Investments
74
104
333
333
333
335
193
202
199
203
Other Long-Term Assets
0
6
0
0
0
0
89
59
77
86
Other Assets
0
2 795
2 795
2 795
2 795
2 795
2 795
2 795
2 795
2 795
Total Assets
5 115
N/A
8 168
+60%
8 856
+8%
10 714
+21%
11 304
+6%
12 310
+9%
13 248
+8%
13 835
+4%
15 798
+14%
18 326
+16%
Liabilities
Accounts Payable
1 118
865
859
1 243
1 223
1 156
1 521
1 174
1 710
1 920
Accrued Liabilities
76
79
79
80
86
226
446
415
591
1 011
Short-Term Debt
1 458
1 236
1 511
1 992
1 491
1 682
570
922
112
0
Current Portion of Long-Term Debt
87
130
112
165
217
156
276
371
392
413
Other Current Liabilities
212
418
295
189
253
357
872
749
1 585
934
Total Current Liabilities
2 951
2 728
2 856
3 669
3 270
3 576
3 685
3 632
4 390
4 277
Long-Term Debt
332
332
298
1 035
607
800
977
1 112
781
541
Deferred Income Tax
124
26
151
128
112
478
598
567
583
604
Minority Interest
2
0
0
0
0
0
0
0
0
0
Other Liabilities
91
83
95
302
322
357
123
119
103
76
Total Liabilities
3 502
N/A
3 169
-10%
3 400
+7%
5 134
+51%
4 310
-16%
5 210
+21%
5 383
+3%
5 430
+1%
5 857
+8%
5 499
-6%
Equity
Common Stock
90
90
90
90
129
129
129
129
129
129
Retained Earnings
853
4 236
4 693
4 813
1 869
1 980
2 761
3 361
4 932
7 804
Additional Paid In Capital
663
663
664
664
4 978
4 978
4 978
4 978
4 978
4 978
Unrealized Security Profit/Loss
8
9
13
13
13
12
3
27
61
53
Other Equity
0
1
3
1
4
0
6
35
36
31
Total Equity
1 614
N/A
4 999
+210%
5 456
+9%
5 580
+2%
6 993
+25%
7 100
+2%
7 865
+11%
8 405
+7%
9 941
+18%
12 827
+29%
Total Liabilities & Equity
5 115
N/A
8 168
+60%
8 856
+8%
10 714
+21%
11 304
+6%
12 310
+9%
13 248
+8%
13 835
+4%
15 798
+14%
18 326
+16%
Shares Outstanding
Common Shares Outstanding
9
9
9
9
13
13
13
13
13
13

See Also

Discover More